ATE86615T1 - Substituierte hydantoinderivate. - Google Patents

Substituierte hydantoinderivate.

Info

Publication number
ATE86615T1
ATE86615T1 AT88301474T AT88301474T ATE86615T1 AT E86615 T1 ATE86615 T1 AT E86615T1 AT 88301474 T AT88301474 T AT 88301474T AT 88301474 T AT88301474 T AT 88301474T AT E86615 T1 ATE86615 T1 AT E86615T1
Authority
AT
Austria
Prior art keywords
group
alkyl
phenyl
alkoxy
aryl
Prior art date
Application number
AT88301474T
Other languages
English (en)
Inventor
Alan Duncan Robertson
Michael Gerard Kelly
Paul Neil Wallace
Heather Giles
Paul Leff
Raymond James Stepney
Gonapushnie Singaram
Original Assignee
Wellcome Found
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Wellcome Found filed Critical Wellcome Found
Application granted granted Critical
Publication of ATE86615T1 publication Critical patent/ATE86615T1/de

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/54—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D233/66—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/72—Two oxygen atoms, e.g. hydantoin
    • C07D233/80—Two oxygen atoms, e.g. hydantoin with hetero atoms or acyl radicals directly attached to ring nitrogen atoms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P27/00—Drugs for disorders of the senses
    • A61P27/16—Otologicals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P35/00—Antineoplastic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Public Health (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Hydrogenated Pyridines (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
AT88301474T 1987-02-23 1988-02-22 Substituierte hydantoinderivate. ATE86615T1 (de)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB878704158A GB8704158D0 (en) 1987-02-23 1987-02-23 Substituted hydantoin compounds
EP88301474A EP0284202B1 (de) 1987-02-23 1988-02-22 Substituierte Hydantoinderivate

Publications (1)

Publication Number Publication Date
ATE86615T1 true ATE86615T1 (de) 1993-03-15

Family

ID=10612743

Family Applications (1)

Application Number Title Priority Date Filing Date
AT88301474T ATE86615T1 (de) 1987-02-23 1988-02-22 Substituierte hydantoinderivate.

Country Status (9)

Country Link
EP (1) EP0284202B1 (de)
JP (1) JPS63253072A (de)
AT (1) ATE86615T1 (de)
AU (1) AU1204688A (de)
DE (1) DE3878952T2 (de)
ES (1) ES2053721T3 (de)
GB (1) GB8704158D0 (de)
GR (1) GR3007318T3 (de)
ZA (1) ZA881224B (de)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO1999042450A1 (en) 1998-02-20 1999-08-26 The Procter & Gamble Company Solid phase synthesis of 1-aminohydantoins
DE60027718T2 (de) * 1999-06-22 2007-05-16 Takeda Pharmaceutical Co. Ltd. Acylhydrazinderivate, verfahren zu ihrer herstellung und ihre verwendung
BR0109050A (pt) 2000-03-09 2004-04-27 Ono Pharmaceutical Co Derivados de indol, processo para prepapação e uso dos mesmos
US20050215609A1 (en) * 2002-09-30 2005-09-29 Masaaki Yoshikawa Novel uses of prostaglandin d2, prostaglandin d2 agonist and prostaglandin d2 antagonist
WO2004058164A2 (en) 2002-12-20 2004-07-15 Tularik, Inc. Asthma and allergic inflammation modulators
EA201001029A1 (ru) 2007-12-19 2011-06-30 Амген Инк. Производные фенилуксусной кислоты в качестве модуляторов процесса воспаления

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DK75884A (da) * 1983-02-18 1984-08-19 Wellcome Found Heterocycliske forbindelser, deres syntese, praeparater, der indeholder dem, og deres medicinske anvendelse

Also Published As

Publication number Publication date
ES2053721T3 (es) 1994-08-01
ZA881224B (en) 1989-10-25
AU1204688A (en) 1988-08-25
EP0284202B1 (de) 1993-03-10
GR3007318T3 (de) 1993-07-30
JPS63253072A (ja) 1988-10-20
DE3878952D1 (de) 1993-04-15
DE3878952T2 (de) 1993-07-08
EP0284202A1 (de) 1988-09-28
GB8704158D0 (en) 1987-04-01

Similar Documents

Publication Publication Date Title
MY106980A (en) Heterocyclic compounds
LU91196I2 (fr) Picoxystrobin et ses dérivlés pharmaceutiquement acceptables(ACANTO).
ES2032229T3 (es) Inhibidores de proteasas benzamidicos.
DK0479546T3 (da) Piperazinderivater
SE8302694L (sv) Immunomudulerande medel
ATE86615T1 (de) Substituierte hydantoinderivate.
IT1219689B (it) Perossiacidi azotati monopersolfati
FI923774A0 (fi) 1,7-anellerande 2-(piperazinoalkyl) indolderivat samt foerfaranden och mellanprodukter foer deras framstaellning.
BR8805578A (pt) Compostos catalisadores de polimerizacao e composicao de polimero
DE69734952D1 (de) Anilide als ACAT-Hemmer
ES2057608T3 (es) Derivado de 1-fenilalquil-3-fenilurea.
ES8600250A1 (es) Un procedimiento de preparacion de derivados de hidantoina
NO932815L (no) Lipoksygenase-inhiberende hydroksamsyre og n-hydroksy-urinstoffderivater
DK1144408T3 (da) Substituerede N-(piperidin-4-yl)-4H-3,1-benzo(thia/oxa)zin-2-aminer, fremstilling deraf og terapeutisk anvendelse deraf
KR910006259A (ko) 벤조-1,2,3-티아디아졸 유도체 및 그의 제조방법
FI824407L (fi) Foerfarande foer framstaellning av vid behandling av magsaor anvaendbara pyrimidinderivat
IT1228426B (it) Perossiacidi eterociclici
ATE96318T1 (de) Acylaminoalkylpyridinamide als inhibitoren der tumormetastasierung.
ATE111456T1 (de) N-alkylthiazolidinderivate.
DK579489D0 (da) Heterocykliske forbindelser
DK284080A (da) Fremgangsmaade til fremstilling af clavulansyrederivater

Legal Events

Date Code Title Description
UEP Publication of translation of european patent specification
REN Ceased due to non-payment of the annual fee